1-2 of 2
Lin Liu, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study of Pegylated Asparaginase, Cyclophosphamide, Rituximab, and Dasatinib Added to the UCSF 8707 (Linker 4-drug) Regimen with Liposomal Cytarabine CNS Prophylaxis for Adults with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL): University of California Hematologic Malignancies Consortium Study (UCHMC) 1401

Matthew J. Wieduwilt, MD PhD, Brian A. Jonas, MD, Gary J. Schiller, MD, Lin Liu, PhD, Carolyn Mulroney, MD, Gabriel N. Mannis, MD, Dimitrios Tzachanis, MD PhD, Januario E. Castro, MD, Edward D Ball, MD, Peter T. Curtin, MD, Charalambos Andreadis, MD, Aaron C. Logan, MD PhD, Jesika Reiner, MPH, Lloyd E. Damon, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4018.
https://doi.org/10.1182/blood-2018-99-117469
Published: 2018
Journal Articles

Intermediate Dose Cyclophosphamide Followed by Sequential GM-CSF and G-CSF: An Efficient and Predictable PBPC Mobilization Regimen for Autografting: A Single Center Study of Two Hundred and Thirty Patients.

Thomas A. Lane, MD, Lin Liu, PhD, Anita Ihasz, Bridget Medina, Sue Corringham, RN, Peter Holman, MD, Ewa Carrier, MD, Januario Castro, MD, Edward D. Ball, MD, Asad Bashey, MD
Journal: Blood
Blood (2005) 106 (11): 5281.
https://doi.org/10.1182/blood.V106.11.5281.5281
Published: 2005